CLASS II Drug recall · Reported 2 Sep 2020 · FDA Enforcement Report

Rocky Mountain Sunscreen SPF30 Kiwi Flavored Lip Balm recalled

Yusef Manufacturing Laboratories is recalling Rocky Mountain Sunscreen SPF30 Kiwi Flavored Lip Balm (Oxybenzone 5%, Meradimate 5%, distributed in Colorado. The recall was initiated on 3 Jun 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPart ID 9PRKY01, Batch #13852
Quantity recalled2,558 pieces

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1540-2020
FDA event ID
85814
Recalling firm
Yusef Manufacturing Laboratories, Clearfield, UT
Classification
Class II
Status
Terminated
Recall initiated
3 Jun 2020
FDA classified
24 Aug 2020
Reported
2 Sep 2020
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

3 Jun 2020Recall initiated by company
24 Aug 2020Classified by FDA+82 days
2 Sep 2020Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Superpotent Drug: Active Ingredient Octisalate found at 15% above label claim.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Rocky Mountain Sunscreen SPF30 Kiwi Flavored Lip Balm (Oxybenzone 5%, Meradimate 5%, Octinoxate 7.5%, Octisalate 5%) 0.15 Oz Tube, Rocky Mtn. Sunscreen, UPC 7 54018 20004 3

Where it was distributed

Shipped to one distributer located in Colorado

Colorado

Questions about this recall

Is Rocky Mountain Sunscreen SPF30 Kiwi Flavored Lip Balm (Oxybenzone 5%, Meradimate 5% recalled?

Yes. Yusef Manufacturing Laboratories recalled Rocky Mountain Sunscreen SPF30 Kiwi Flavored Lip Balm (Oxybenzone 5%, Meradimate 5% on 3 Jun 2020. The recall is Class II and its status is Terminated. Recall number D-1540-2020.

Why was it recalled?

Superpotent Drug: Active Ingredient Octisalate found at 15% above label claim.

Which lots are affected?

Part ID 9PRKY01, Batch #13852

Where was it sold?

Shipped to one distributer located in Colorado

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Yusef Manufacturing Laboratories

All 3